10.1 C
New York
Wednesday, April 24, 2024

Morning Market Gainers

Courtesy of Benzinga.

Related
Oragenics, Inc. to Explore Strategic Alternatives for its OTC Probiotic Products Business
Exclusive: Oragenics CEO John Bonfiglio Talks Intrexon, Lantibiotics

Related CYT
UPDATE: Cytec Confirms Acquisition by Solvay for $75.25/Share in Cash
Solvay to Acquire Cytec for $75.25/Share in Cash
Stock Futures Modestly Higher; Twitter, Yelp, Tableau Slammed (Investor’s Business Daily)

Oragenics Inc (NYSE: OGEN) shares surged 43.68 percent to $2.50 after the company reported positive data for multiple compounds from its Mutacin 1140 lantibiotic platform.

Cytec Industries Inc (NYSE: CYT) shares climbed 26.22 percent to $73.71 after Belgium’s Solvay announced its plans to buy Cytec for $5.5 billion.

Strayer Education Inc (NASDAQ: STRA) jumped 20.26 percent to $50.22 after the company reported stronger-than-expected Q2 results.

Natural Health Trends Corp. (NASDAQ: NHTC) surged 20.27 percent to $29.73 after the company reported Q2 results and lifted its dividend by 33 percent to $0.04 per share. The company’s board authorized a $15 million share repurchase.

The Rubicon Project Inc (NYSE: RUBI) gained 15.39 percent to $17.77 on upbeat Q2 results.

Calix Inc (NYSE: CALX) shares rose 14.29 percent to $8.00 after the company reported better-than-expected Q2 results.

Buffalo Wild Wings (NASDAQ: BWLD) surged 11.47 percent to $190.92 after the company reported its quarterly financial results.

Citrix Systems, Inc. (NASDAQ: CTXS) shares jumped 6.04 percent to $73.83 after the company reported upbeat Q2 earnings and announced that Chief Executive Mark Templeton will retire.

Gilead Sciences, Inc. (NASDAQ: GILD) shares gained 4.77 percent to $118.46 as the company reported better-than-expected earnings for the second quarter and raised its FY15 sales forecast.

Posted-In: Market GainersNews Intraday Update Markets Movers

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,328FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x